Welcome back to Under the Hood, where we'll cover all the action for the week ended February 2, 2024. This report is published bi-weekly, in rotation with The Minor Leaguers.
What we do here is analyze the most popular stocks during the week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.
We use a variety of sources to generate the list of most popular names.
There are so many new data sources available that all we need to do is organize and curate them in a way that shows us exactly what we want: a list of stocks that are seeing an unusual increase in investor interest.
If silver doesn’t come to play, precious metals won’t win the day.
Gold’s resilience has been impressive lately, especially as its two main headwinds – the US dollar and real yields – catch higher.
But while all eyes are following gold as it coils just below all-time highs, I’m tracking silver. Because gold’s doggedness is all for naught if silver breaks down.
— Sean McLaughlin, NLD 📈 ( formerly @chicagosean) (@OptionsSean) February 5, 2024
Today on The Flow Show, me and Steve Strazza chatted about the current $VIX environment, the potential for sideways, volatile trading action, and our internally diverging views on the overall market (JC is getting more bearish, Strazza is still flying the Bull Flag, and I'm closer to Switzerland).
As we dug into it, Strazza floated a couple ideas in the Healthcare space that made sense to me once we fleshed it out.
If silver doesn’t come to play, precious metals won’t win the day.
Gold’s resilience has been impressive lately, especially as its two main headwinds – the US dollar and real yields – catch higher.
But while all eyes are following gold as it coils just below all-time highs, I’m tracking silver. Because gold’s doggedness is all for naught if silver breaks down.
Check out the iShares Silver Trust ETF $SLV retesting a critical former support level at approximately 20.50: